Proposed Data Collections Submitted for Public Comment and Recommendations, 54659 [E6-15435]
Download as PDF
<![CDATA[
Federal Register / Vol. 71, No. 180 / Monday, September 18, 2006 / Notices
A. Federal Reserve Bank of Boston
(Richard Walker, Community Affairs
Officer) P.O. Box 55882, Boston,
Massachusetts 02106-2204:
1. Marlborough Bancshares, Inc. and
Marlborough Bancshares MHC; to
become bank holding companies by
acquiring 100 percent of the voting
shares of Marlborough Savings Bank, all
of Marlborough, Massachusetts.
B. Federal Reserve Bank of Chicago
(Patrick M. Wilder, Assistant Vice
President) 230 South LaSalle Street,
Chicago, Illinois 60690-1414:
1. PrivateBancorp, Inc., Chicago,
Illinois; to merge with Piedmont
Bancshares, Inc. Atlanta, Georgia, and
thereby indirectly acquire Piedmont
Bank of Georgia, Atlanta, Georgia.
Board of Governors of the Federal Reserve
System, September 12, 2006.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. E6–15371 Filed 9–15–06; 8:45 am]
BILLING CODE 6210–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–06–05BW]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
54659
declined over the past several years, it
ranks fifth among deaths from all
causes. The digital rectal examination
(DRE) and prostate specific antigen
(PSA) test are used to screen for prostate
cancer. Screening is controversial and
many are not in agreement as to whether
the potential benefits of screening
outweigh the risks, that is, if prostate
specific antigen (PSA) based screening,
early detection, and later treatment
increases longevity. Although major
medical organizations are divided on
whether men should be routinely
screened for this disease, it appears that
all of the major organizations
recommend discussion with patients
about the benefits and risks of
screening.
The purpose of this project is to
develop and administer a national
survey to a sample of American primary
care physicians to examine whether or
not they: Screen for prostate cancer
using (PSA and/or DRE), recommend
testing and under what conditions,
discuss the tests and the risks and
benefits of screening with patients, and
if their screening practices vary by
factors such as age, ethnicity, and family
history. This study will examine
demographic, social, and behavioral
characteristics of physicians as they
relate to screening and related issues,
including knowledge and awareness,
beliefs regarding efficacy of screening
and treatment, frequency of screening,
awareness of the screening controversy,
influence of guidelines from medical
practices and other organizations, and
participation and/or willingness to
participate in shared decision-making.
There will be no cost to respondents
other than their time to participate in
the survey.
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Seleda Perryman,
CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS–D74,
Atlanta, GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Survey of Primary Care Physicians’
Practices regarding Prostate Cancer
Screening—New—National Center for
Chronic Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Prostate cancer is the most common
cancer in men and is the second leading
cause of cancer deaths, behind lung
cancer. The American Cancer Society
estimates that there will be about
234,460 new cases of prostate cancer
and about 27,350 deaths in 2006.
Although prostate cancer deaths have
ESTIMATED ANNUALIZED BURDEN HOURS
Respondents
Number of
respondents
Number of
responses per
respondents
Average
burden per response
(in hours)
Total burden
(in hours)
Primary Care Physicians .................................................................................
2,000
1
30/60
1,000
cprice-sewell on PROD1PC66 with NOTICES
Dated: September 11, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E6–15435 Filed 9–15–06; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4163–18–P
[60Day–06–06BR]
Centers for Disease Control and
Prevention
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
VerDate Aug<31>2005
14:48 Sep 15, 2006
Jkt 208001
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Seleda Perryman,
CDC Assistant Reports Clearance
E:\FR\FM\18SEN1.SGM
18SEN1
]]>Agencies
[Federal Register Volume 71, Number 180 (Monday, September 18, 2006)]
[Notices]
[Page 54659]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-15435]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-06-05BW]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-5960
and send comments to Seleda Perryman, CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail
to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
Survey of Primary Care Physicians' Practices regarding Prostate
Cancer Screening--New--National Center for Chronic Disease Prevention
and Health Promotion (NCCDPHP), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Prostate cancer is the most common cancer in men and is the second
leading cause of cancer deaths, behind lung cancer. The American Cancer
Society estimates that there will be about 234,460 new cases of
prostate cancer and about 27,350 deaths in 2006. Although prostate
cancer deaths have declined over the past several years, it ranks fifth
among deaths from all causes. The digital rectal examination (DRE) and
prostate specific antigen (PSA) test are used to screen for prostate
cancer. Screening is controversial and many are not in agreement as to
whether the potential benefits of screening outweigh the risks, that
is, if prostate specific antigen (PSA) based screening, early
detection, and later treatment increases longevity. Although major
medical organizations are divided on whether men should be routinely
screened for this disease, it appears that all of the major
organizations recommend discussion with patients about the benefits and
risks of screening.
The purpose of this project is to develop and administer a national
survey to a sample of American primary care physicians to examine
whether or not they: Screen for prostate cancer using (PSA and/or DRE),
recommend testing and under what conditions, discuss the tests and the
risks and benefits of screening with patients, and if their screening
practices vary by factors such as age, ethnicity, and family history.
This study will examine demographic, social, and behavioral
characteristics of physicians as they relate to screening and related
issues, including knowledge and awareness, beliefs regarding efficacy
of screening and treatment, frequency of screening, awareness of the
screening controversy, influence of guidelines from medical practices
and other organizations, and participation and/or willingness to
participate in shared decision-making. There will be no cost to
respondents other than their time to participate in the survey.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Respondents Number of responses per per response Total burden
respondents respondents (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
Primary Care Physicians..................... 2,000 1 30/60 1,000
----------------------------------------------------------------------------------------------------------------
Dated: September 11, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. E6-15435 Filed 9-15-06; 8:45 am]
BILLING CODE 4163-18-P
